Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (481-490 of 622) with videos related to

Pageof 63
Sort By:
Autoimmunity Reviews|February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committeeCorrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Rheumatology Advances in Practice|January 23, 2025
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) studySaadia Sasha Ali, Christiana Demetriou, Ioannis Parodis, et al.
International Journal of Cardiology|January 7, 2012
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011H Ardeschir Ghofrani, Oliver Distler, Felix Gerhardt, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.
JCI Insight|July 16, 2024
Radioproteomics stratifies molecular response to antifibrotic treatment in pulmonary fibrosisDavid Lauer, Cheryl Y Magnin, Luca R Kolly, et al.
Rheumatology (Oxford, England)|December 7, 2013
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysisAndrea D Keck, Chingching Foocharoen, Edoardo Rosato, et al.
Nature Communications|December 9, 2023
The long non-coding RNA HOTAIR contributes to joint-specific gene expression in rheumatoid arthritisMuriel Elhai, Raphael Micheroli, Miranda Houtman, et al.
Thorax|October 5, 2023
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysisSabina Guler, Adela-Cristina Sarbu, Odile Stalder, et al.
Pageof 63

Showing results (481-490 of 622) with videos related to

Sort By:
Pageof 63
Autoimmunity Reviews|February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committeeCorrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Rheumatology Advances in Practice|January 23, 2025
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) studySaadia Sasha Ali, Christiana Demetriou, Ioannis Parodis, et al.
International Journal of Cardiology|January 7, 2012
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011H Ardeschir Ghofrani, Oliver Distler, Felix Gerhardt, et al.
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
Rheumatology (Oxford, England)|July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosisHana Sabanovic, John D Pauling, Murray Baron, et al.
RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.
JCI Insight|July 16, 2024
Radioproteomics stratifies molecular response to antifibrotic treatment in pulmonary fibrosisDavid Lauer, Cheryl Y Magnin, Luca R Kolly, et al.
Rheumatology (Oxford, England)|December 7, 2013
Nailfold capillary abnormalities in erectile dysfunction of systemic sclerosis: a EUSTAR group analysisAndrea D Keck, Chingching Foocharoen, Edoardo Rosato, et al.
Nature Communications|December 9, 2023
The long non-coding RNA HOTAIR contributes to joint-specific gene expression in rheumatoid arthritisMuriel Elhai, Raphael Micheroli, Miranda Houtman, et al.
Thorax|October 5, 2023
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysisSabina Guler, Adela-Cristina Sarbu, Odile Stalder, et al.
Pageof 63